Distinctive expression pattern of OCT4 variants in different types of breast cancer

Nichols J. , Zevnik B. , Anastassiadis K. , Niwa H. , Klewe-Nebenius D. , Chambers I. , Schöer H. and Smith A. , Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4, Cell 95 (1998), 379-391.

Boiani M. and Schöer H.R. , Regulatory networks in embryo-derived pluripotent stem cells, Nature Reviews Molecular Cell Biology 6 (2005), 872-881.

Pardal R. , Clarke M.F. and Morrison S.J. , Applying the principles of stem-cell biology to cancer, Nature Reviews Cancer 3 (2003), 895-902.

Al-Hajj M. and Clarke M.F. , Self-renewal and solid tumor stem cells, Oncogene 23 (2004), 7274-7282.

Clarke M.F. and Fuller M. , Stem cells and cancer: two faces of eve, Cell 124 (2006), 1111-1115.

Cao L. , Li C. , Shen S. , Yan Y. , Ji W. , Wang J. , Qian H. , Jiang X. , Li Z. and Wu M. , OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma, BMC Cancer 13 (2013), 82.

Wen J. , Park J.Y. , Park K.H. , Chung H.W. , Bang S. , Park S.W. and Song S.Y. , Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis, Pancreas 39 (2010), 622-626.

Wei D. , Kanai M. , Jia Z. , Le X. and Xie K. , Krüpel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells, Cancer Research 68 (2008), 4631-4639.

Papamichos S.I. , Kotoula V. , Tarlatzis B.C. , Agorastos T. , Papazisis K. and Lambropoulos A.F. , OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness, Molecular Human Reproduction 15 (2009), 269-270.

Atlasi Y. , Mowla S.J. , Ziaee S.A. and Bahrami A.R. , OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer, International Journal of Cancer 120 (2007), 1598-602.

Takeda J. , Seino S. and Bell G.I. , Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues, Nucleic Acids Research 20 (1992), 4613-4620.

Atlasi Y. , Mowla S.J. , Ziaee S.A.M. , Gokhale P.J. and Andrews P.W. , OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells, Stem Cells 26 (2008), 3068-3974.

Lee J. , Kim H.K. , Rho J.Y. , Han Y.M. and Kim J. , The human OCT-4 isoforms differ in their ability to confer self-renewal, Journal of Biological Chemistry 281 (2006), 33554-33565.

Cauffman G. , Liebaers I. , Van Steirteghem A. and Van de Velde H. , POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos, Stem Cells 24 (2006), 2685-2691.

Asadi M.H. , Mowla S.J. , Fathi F. , Aleyasin A. , Asadzadeh J. and Atlasi Y. , OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor, International Journal of Cancer 128 (2011), 2645-2652.

Asadzadeh J. , Asadi M.H. , Shakhssalim N. , Rafiee M.R. , Kalhor H.R. , Tavallaei M. and Mowla S.J. , A Plausible Anti-Apoptotic Role of Up-Regulated OCT4B1 in Bladder Tumors, Urology Journal 9 (2012), 574-580.

Mirzaei M.R. , Najafi A. , Arababadi M.K. , Asadi M.H. and Mowla S.J. , Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines, Tumor Biology 35 (2014), 9999-10009.

Mirzaei M.R. , Arababadi M.K. , Asadi M.H. and Mowla S.J. , Altered Expression of High Molecular Weight Heat Shock Proteins after OCT4B1 Suppression in Human Tumor Cell Lines, Cell Journal 17 (2016), 608-616.

Mirzaei M.R. , Asadi M.H. , Mowla S.J. , Hassanshahi G. and Ahmadi Z. , Down-regulation of HSP40 gene family following OCT4B1 suppression in human tumor cell lines, Iran J Basic Med Sci, 19 (2016), 187-193.

Torre L.A. , Bray F. , Siegel R.L. , Ferlay J. , Tieulent J.L. and Jemal A. , Global Cancer Statistics, 2012, CA: A Cancer Journal for Clinicians 65 (2015), 87-108.

Schöer H.R. , Ruppert S. , Suzuki N. , Chowdhury K. and Gruss P. , New type of POU domain in germ line-specific protein Oct-4, Nature 29 (1990), 435-439.

Rosner M.H. , Vigano M.A. , Ozato K. , Timmons P.M. , Poirie F. , Rigby P.W. and Staudt L.M. , A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo, Nature 345 (1990), 686-692.

Radzisheuskaya A. and Silva J.C.R. , Do all roads lead to Oct4? The emerging concepts of induced pluripotency, Trends in Cell Biology 24 (2014), 275-284.

Amin R. and Mishra L. , Liver Stem Cells and TGF-β in Hepatic Carcinogenesis, Gastrointest Cancer Res 2 (2008), 27-30.

Looijenga L.H. , Stoop H. , de Leeuw H.P.J.C. , de Gouveia Brazao C.A. , Gillis A.J.M. , van Roozendaal K.E.P. , van Zoelen E.J.J. , Weber R.F.A. , Wolffenbuttel K.P. , van Dekken H. , Honecker F. , Bokemeyer C. , Perlman E.J. , Schneider D.T. , Kononen J. , Sauter G. and Oosterhuis J.W. , POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors, Cancer Research 63 (2003), 2244-50.

Li X. , Wang J. , Xu Z. , Ahmad A. , Li E. , Wang Y. , Qin S. and Wang Q. , Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer, International Journal of Molecular Sciences 13 (2012), 7663-75.

Ezeh U.I. , Turek P.J. , Reijo Pera R.A. and Clark A.T. , Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma, Cancer 104 (2005), 2255-65.

Gibbs C.P. , Kukekov V.G. , Reith J.D. , Tchigrinova O. , Suslov O.N. , Scott E.W. , Ghivizzani S.C. , Ignatova T.N. and Steindler D.A. , Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis, Neoplasia 7 (2005), 967-976.

Jin T. , Branch D.R. , Zhang X. , Qi S. , Youngson B. and Goss P.E. , Examination of POU homeobox gene expression in human breast cancer cells, International Journal of Cancer 81 (1999), 104-12.

Wang Q. , Zhang J.G. and Wang W. , Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages, Genetics and Molecular Research 14 (2015), 6844-6851.

Wang P. , Branch D.R. , Bali M. , Schultz G.A. , Goss P.E. and Jin T. , The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells, Biochem J 375 (2003), 199-205.

Tai M.H. , Chang C.C. , Olson L.K. and Trosko J.E. , Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis, Carcinogenesis 26 (2005), 495-502.

Wezel F. , Pearson J. , Kirkwood L.A. and Southgate J. , Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer, The American journal of pathology 183 (2013), 1128-1136.

Gazouli M. , Roubelakis M.G. , Theodoropoulos G.E. , Papailiou J. , Vaiopoulou A. , Pappa K.I. , Nikiteas N. and Anagnou N.P. , OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer, Molecular Carcinogenesis 51 (2012), 165-173.

Hatefi N. , Nouraee N. , Parvin M. , Ziaee S.A.M. and Mowla S.J. , Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer, Iranian Journal of Basic Medical Sciences 15 (2012), 1154.

Gao Y. , Wei J. , Han J. , Wang X. , Su G. , Zhao Y. , Chen B. , Xiao Z. , Cao J. and Dai J. , The novel function of OCT4B isoform-265 in genotoxic stress, Stem Cells 30 (2012), 665-72.

Li S.W. , Wu X.L. , Dong C.L. , Xie X.Y. , Wu J.F. and Zhang X. , The Differential Expression of OCT4 Isoforms in Cervical Carcinoma, PLoS One 10 (2015), e0118033.

Li D. , Yang Z.K. , Bu J.Y. , Xu C.Y. , Sun H. , Tang J.B. , Lin P. , Cheng W. , Huang N. , Cui R.J. , Yu X.G. and Zheng X.L. , OCT4B modulates OCT4A expression as ceRNA in tumor cells, Oncology Reports 33 (2015) 2622-30.

Jung J.W. , Park S.B. , Lee S.J. , Seo M.S. , Trosko J.E. and Kan K.S. , Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression, PLoS One 6 (2011), e28068.

Beltran A.S. , Rivenbark A.G. , Richardson B.T. , Yuan X. , Quian H. , Hunt J.P. , Zimmerman E. , Graves L.M. and Blancafort P. , Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor, Breast Cancer Research 13 (2011), R94.

Simoes B.M. , Piva M. , Iriondo O. , Comaills V. , Loṕez-Ruiz J.A. , Zabalza I. , Mieza J.A. , Acinas O. and Vivanco M.D.M. , Effects of estrogen on the proportion of stem cells in the breast, Breast Cancer Res, Treat 129 (2011), 23-35.

Stossi F. , Likhite V.S. , Katzenellenbogen J.A. and Katzenellenbogen B.S. , Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter, Journal of Biological Chemistry 281 (2006), 16272-278.

Oak P.S. , Kopp F. , Thakur C. , Ellwart J.W. , Rapp U.R. , Ullrich A. , Wagner E. , Knyazev P. and Roidl A. , Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells, International Journal of Cancer 131 (2012), 2808-2819.

Karunagaran D. , Tzahar E. , Beerli R.R. , Chen X. , Graus-Porta D. , Ratzkin B.J. , Seger R. , Hynes N.E. and Yarden Y. , ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer, EMBO Journal 15 (1996), 254-264.

Aranda V. , Haire T. , Nolan M.E. , Calarco J.P. , Rosenberg A.Z. , Fawcett J.P. , Pawson T. and Muthuswamy S.K. , Par6 - aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control, Nature Cell Biology 8 (2006), 1235-1245.